Cargando...

艾曲泊帕治疗儿童原发免疫性血小板减少症23例临床观察

OBJECTIVE: To evaluate the efficacy and safety of eltrombopag in the treatment of pediatric primary immune thrombocytopenia (ITP) . METHODS: The clinical characteristics of 23 pediatric ITP patients who received eltrombopag from May 2015 to March 2019 were retrospectively analyzed. Eltrombopag start...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Zhonghua Xue Ye Xue Za Zhi
Formato: Artigo
Idioma:Inglês
Publicado: Editorial office of Chinese Journal of Hematology 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342689/
https://ncbi.nlm.nih.gov/pubmed/32023736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.012
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!